company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2010.0,Q3,2010-04-01,2010-06-30,2011-08-09 14:48:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,487350.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2010.0,Q3,2010-04-01,2010-06-30,2011-08-09 14:48:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,487350.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2010.0,Q3,2010-04-01,2010-06-30,2011-08-09 14:48:13+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,80000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2010.0,Q3,2010-04-01,2010-06-30,2011-08-09 14:48:13+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,80000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2010.0,Q3,2010-04-01,2010-06-30,2011-08-09 14:48:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,407350.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2010.0,Q3,2010-04-01,2010-06-30,2011-08-09 14:48:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3733151.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2010.0,Q3,2010-04-01,2010-06-30,2011-08-09 14:48:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2788132.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2010.0,Q3,2010-04-01,2010-06-30,2011-08-09 14:48:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6521283.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2010.0,Q3,2010-04-01,2010-06-30,2011-08-09 14:48:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6113933.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2010.0,Q3,2010-04-01,2010-06-30,2011-08-09 14:48:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2661.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2010.0,Q3,2010-04-01,2010-06-30,2011-08-09 14:48:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,389689.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2010.0,Q3,2010-04-01,2010-06-30,2011-08-09 14:48:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,392350.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2010.0,Q3,2010-04-01,2010-06-30,2011-08-09 14:48:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5721583.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2010.0,Q3,2010-04-01,2010-06-30,2011-08-09 14:48:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5721583.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2010.0,Q3,2010-04-01,2010-06-30,2011-08-09 14:48:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5721583.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2010.0,Q3,2010-04-01,2010-06-30,2011-08-09 14:48:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5721583.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2010.0,Q3,2010-04-01,2010-06-30,2011-08-09 14:48:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,95400000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2010.0,Q3,2010-04-01,2010-06-30,2011-08-09 14:48:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2010.0,Q3,2010-04-01,2010-06-30,2011-08-09 14:48:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,95400000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2010.0,Q3,2010-04-01,2010-06-30,2011-08-09 14:48:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2010.0,Q3,2010-04-01,2010-06-30,2011-08-09 14:48:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,89347783.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2010.0,Q3,2010-04-01,2010-06-30,2011-08-09 14:48:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q1,2010-10-01,2010-12-31,2012-02-08 16:27:39+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1818487.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q1,2010-10-01,2010-12-31,2012-02-08 16:27:39+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,0.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q1,2010-10-01,2010-12-31,2012-02-08 16:27:39+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1818487.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q1,2010-10-01,2010-12-31,2012-02-08 16:27:39+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q1,2010-10-01,2010-12-31,2012-02-08 16:27:39+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1818487.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q1,2010-10-01,2010-12-31,2012-02-08 16:27:39+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10093438.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q1,2010-10-01,2010-12-31,2012-02-08 16:27:39+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3843789.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q1,2010-10-01,2010-12-31,2012-02-08 16:27:39+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13937227.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q1,2010-10-01,2010-12-31,2012-02-08 16:27:39+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12118740.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q1,2010-10-01,2010-12-31,2012-02-08 16:27:39+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,7132.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q1,2010-10-01,2010-12-31,2012-02-08 16:27:39+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-311.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q1,2010-10-01,2010-12-31,2012-02-08 16:27:39+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,6821.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q1,2010-10-01,2010-12-31,2012-02-08 16:27:39+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12111919.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q1,2010-10-01,2010-12-31,2012-02-08 16:27:39+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12111919.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q1,2010-10-01,2010-12-31,2012-02-08 16:27:39+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12111919.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q1,2010-10-01,2010-12-31,2012-02-08 16:27:39+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12111919.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q1,2010-10-01,2010-12-31,2012-02-08 16:27:39+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,110100000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q1,2010-10-01,2010-12-31,2012-02-08 16:27:39+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q1,2010-10-01,2010-12-31,2012-02-08 16:27:39+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,110100000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q1,2010-10-01,2010-12-31,2012-02-08 16:27:39+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q1,2010-10-01,2010-12-31,2012-02-08 16:27:39+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,108396709.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q1,2010-10-01,2010-12-31,2012-02-08 16:27:39+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q2,2011-01-01,2011-03-31,2012-05-09 16:57:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1479455.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q2,2011-01-01,2011-03-31,2012-05-09 16:57:04+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-42952.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q2,2011-01-01,2011-03-31,2012-05-09 16:57:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1436503.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q2,2011-01-01,2011-03-31,2012-05-09 16:57:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,114327.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q2,2011-01-01,2011-03-31,2012-05-09 16:57:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,114327.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q2,2011-01-01,2011-03-31,2012-05-09 16:57:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1322176.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q2,2011-01-01,2011-03-31,2012-05-09 16:57:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13278773.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q2,2011-01-01,2011-03-31,2012-05-09 16:57:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2519390.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q2,2011-01-01,2011-03-31,2012-05-09 16:57:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15798163.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q2,2011-01-01,2011-03-31,2012-05-09 16:57:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14475987.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q2,2011-01-01,2011-03-31,2012-05-09 16:57:04+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,10051.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q2,2011-01-01,2011-03-31,2012-05-09 16:57:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,348.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q2,2011-01-01,2011-03-31,2012-05-09 16:57:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,10399.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q2,2011-01-01,2011-03-31,2012-05-09 16:57:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14465588.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q2,2011-01-01,2011-03-31,2012-05-09 16:57:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14465588.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q2,2011-01-01,2011-03-31,2012-05-09 16:57:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14465588.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q2,2011-01-01,2011-03-31,2012-05-09 16:57:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14465588.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q2,2011-01-01,2011-03-31,2012-05-09 16:57:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,120500000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q2,2011-01-01,2011-03-31,2012-05-09 16:57:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q2,2011-01-01,2011-03-31,2012-05-09 16:57:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,120500000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q2,2011-01-01,2011-03-31,2012-05-09 16:57:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.12
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q2,2011-01-01,2011-03-31,2012-05-09 16:57:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,121635339.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q2,2011-01-01,2011-03-31,2012-05-09 16:57:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.12
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 14:48:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,547900.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 14:48:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,547900.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 14:48:13+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,-1813027.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 14:48:13+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,-1813027.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 14:48:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2360927.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 14:48:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15150053.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 14:48:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3258950.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 14:48:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18409003.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 14:48:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16048076.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 14:48:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,10848.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 14:48:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-28332.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 14:48:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-17484.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 14:48:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16065560.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 14:48:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16065560.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 14:48:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16065560.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 14:48:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16065560.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 14:48:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,123600000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 14:48:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.13
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 14:48:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,123600000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 14:48:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.13
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 14:48:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,123354986.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 14:48:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.13
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6650053.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,42952.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6693005.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2144680.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2144680.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4548325.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,16903327.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5631610.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22534937.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17986612.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,10754.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-9438.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1316.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17985296.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3200.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17988496.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17988496.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17988496.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,118900000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,118900000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,119405230.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7961751.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-796868.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7164883.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,309803.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,309803.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6855080.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,19075019.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3744515.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22819534.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15964454.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,14291.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4006.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,18297.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15946157.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15946157.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15946157.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15946157.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,132900000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,132900000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.12
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,127934257.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.12
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,2013-05-08 18:14:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10040388.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,2013-05-08 18:14:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10040388.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,2013-05-08 18:14:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,534345.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,2013-05-08 18:14:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,534345.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,2013-05-08 18:14:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9506043.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,2013-05-08 18:14:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5346990.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,2013-05-08 18:14:21+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,14814014.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,2013-05-08 18:14:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6395155.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,2013-05-08 18:14:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26556159.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,2013-05-08 18:14:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17050116.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,2013-05-08 18:14:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,7882.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,2013-05-08 18:14:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,75.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,2013-05-08 18:14:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,7957.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,2013-05-08 18:14:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17042159.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,2013-05-08 18:14:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17042159.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,2013-05-08 18:14:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17042159.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,2013-05-08 18:14:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17042159.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,2013-05-08 18:14:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,131100000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,2013-05-08 18:14:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.13
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,2013-05-08 18:14:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,131100000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,2013-05-08 18:14:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.13
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,2013-05-08 18:14:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,133463300.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,2013-05-08 18:14:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.13
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q3,2012-04-01,2012-06-30,2013-08-08 14:25:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10537996.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q3,2012-04-01,2012-06-30,2013-08-08 14:25:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10537996.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q3,2012-04-01,2012-06-30,2013-08-08 14:25:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,563527.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q3,2012-04-01,2012-06-30,2013-08-08 14:25:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,563527.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q3,2012-04-01,2012-06-30,2013-08-08 14:25:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9974469.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q3,2012-04-01,2012-06-30,2013-08-08 14:25:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5160414.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q3,2012-04-01,2012-06-30,2013-08-08 14:25:57+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,12694855.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q3,2012-04-01,2012-06-30,2013-08-08 14:25:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6831206.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q3,2012-04-01,2012-06-30,2013-08-08 14:25:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24686475.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q3,2012-04-01,2012-06-30,2013-08-08 14:25:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14712006.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q3,2012-04-01,2012-06-30,2013-08-08 14:25:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,326098.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q3,2012-04-01,2012-06-30,2013-08-08 14:25:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,7890.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q3,2012-04-01,2012-06-30,2013-08-08 14:25:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-318208.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q3,2012-04-01,2012-06-30,2013-08-08 14:25:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15030214.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q3,2012-04-01,2012-06-30,2013-08-08 14:25:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15030214.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q3,2012-04-01,2012-06-30,2013-08-08 14:25:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15030214.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q3,2012-04-01,2012-06-30,2013-08-08 14:25:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15030214.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q3,2012-04-01,2012-06-30,2013-08-08 14:25:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,136600000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q3,2012-04-01,2012-06-30,2013-08-08 14:25:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q3,2012-04-01,2012-06-30,2013-08-08 14:25:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,136600000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q3,2012-04-01,2012-06-30,2013-08-08 14:25:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q3,2012-04-01,2012-06-30,2013-08-08 14:25:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,135825005.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q3,2012-04-01,2012-06-30,2013-08-08 14:25:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12734865.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,796868.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13531733.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,712325.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,712325.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12819408.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,-7554423.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,24954131.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6095124.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23494832.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10675424.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1059902.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,12937.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-81.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1047046.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11722470.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11725470.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11725470.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11725470.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,132800000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,132800000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,133358571.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q1,2012-10-01,2012-12-31,2013-02-08 13:05:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16520272.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q1,2012-10-01,2012-12-31,2013-02-08 13:05:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16520272.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q1,2012-10-01,2012-12-31,2013-02-08 13:05:29+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,847527.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q1,2012-10-01,2012-12-31,2013-02-08 13:05:29+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,847527.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q1,2012-10-01,2012-12-31,2013-02-08 13:05:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15672745.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q1,2012-10-01,2012-12-31,2013-02-08 13:05:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6538403.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q1,2012-10-01,2012-12-31,2013-02-08 13:05:29+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,13522419.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q1,2012-10-01,2012-12-31,2013-02-08 13:05:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6648091.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q1,2012-10-01,2012-12-31,2013-02-08 13:05:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26708913.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q1,2012-10-01,2012-12-31,2013-02-08 13:05:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11036168.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q1,2012-10-01,2012-12-31,2013-02-08 13:05:29+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1059245.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q1,2012-10-01,2012-12-31,2013-02-08 13:05:29+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,19331.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q1,2012-10-01,2012-12-31,2013-02-08 13:05:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1039914.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q1,2012-10-01,2012-12-31,2013-02-08 13:05:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12076082.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q1,2012-10-01,2012-12-31,2013-02-08 13:05:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12076082.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q1,2012-10-01,2012-12-31,2013-02-08 13:05:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12076082.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q1,2012-10-01,2012-12-31,2013-02-08 13:05:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12076082.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q1,2012-10-01,2012-12-31,2013-02-08 13:05:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,134200000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q1,2012-10-01,2012-12-31,2013-02-08 13:05:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q1,2012-10-01,2012-12-31,2013-02-08 13:05:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,134200000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q1,2012-10-01,2012-12-31,2013-02-08 13:05:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q1,2012-10-01,2012-12-31,2013-02-08 13:05:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,136772557.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q1,2012-10-01,2012-12-31,2013-02-08 13:05:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,2013-05-08 18:14:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,17434188.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,2013-05-08 18:14:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,17434188.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,2013-05-08 18:14:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1002516.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,2013-05-08 18:14:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1002516.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,2013-05-08 18:14:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16431672.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,2013-05-08 18:14:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6978684.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,2013-05-08 18:14:21+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,16061408.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,2013-05-08 18:14:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8874298.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,2013-05-08 18:14:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,31914390.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,2013-05-08 18:14:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15482718.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,2013-05-08 18:14:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1059245.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,2013-05-08 18:14:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,15065.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,2013-05-08 18:14:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,197.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,2013-05-08 18:14:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1043983.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,2013-05-08 18:14:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16526701.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,2013-05-08 18:14:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16526701.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,2013-05-08 18:14:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16526701.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,2013-05-08 18:14:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16526701.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,2013-05-08 18:14:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,137700000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,2013-05-08 18:14:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,2013-05-08 18:14:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,137700000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,2013-05-08 18:14:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.12
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,2013-05-08 18:14:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,139173746.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,2013-05-08 18:14:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.12
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,2013-08-08 14:25:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19758662.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,2013-08-08 14:25:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19758662.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,2013-08-08 14:25:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1077736.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,2013-08-08 14:25:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1077736.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,2013-08-08 14:25:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18680926.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,2013-08-08 14:25:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7031615.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,2013-08-08 14:25:57+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,16005750.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,2013-08-08 14:25:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6053684.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,2013-08-08 14:25:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,29091049.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,2013-08-08 14:25:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10410123.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,2013-08-08 14:25:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1024462.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,2013-08-08 14:25:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,10183.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,2013-08-08 14:25:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-228.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,2013-08-08 14:25:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1014507.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,2013-08-08 14:25:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11424630.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,2013-08-08 14:25:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11424630.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,2013-08-08 14:25:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11424630.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,2013-08-08 14:25:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11424630.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,2013-08-08 14:25:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,142800000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,2013-08-08 14:25:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,2013-08-08 14:25:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,142800000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,2013-08-08 14:25:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,2013-08-08 14:25:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,145244796.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,2013-08-08 14:25:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21652762.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21652762.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1221955.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1221955.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,20430807.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9386173.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,17612199.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27930126.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,54928498.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-34497691.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,954894.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,7335.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-947559.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-35445250.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3200.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-35448450.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-35448450.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-35448450.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,142400000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.24
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,142400000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.24
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,142269399.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.24
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,25388341.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1358078.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,26746419.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1292411.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1292411.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,25454008.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8449890.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,17475404.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9525320.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,35450614.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9996606.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,954895.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4552.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,412.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-949931.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10946537.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10946537.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10946537.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10946537.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,156400000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,156400000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,152100388.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,2014-05-07 14:30:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,24854440.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,2014-05-07 14:30:25+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,2092264.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,2014-05-07 14:30:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,26946704.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,2014-05-07 14:30:25+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1370001.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,2014-05-07 14:30:25+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1370001.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,2014-05-07 14:30:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,25576703.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,2014-05-07 14:30:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8555381.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,2014-05-07 14:30:25+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,18904244.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,2014-05-07 14:30:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9892256.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,2014-05-07 14:30:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,37351881.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,2014-05-07 14:30:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11775178.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,2014-05-07 14:30:25+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,898316.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,2014-05-07 14:30:25+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4987.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,2014-05-07 14:30:25+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-9249.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,2014-05-07 14:30:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-902578.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,2014-05-07 14:30:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12677756.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,2014-05-07 14:30:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12677756.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,2014-05-07 14:30:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12677756.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,2014-05-07 14:30:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12677756.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,2014-05-07 14:30:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,158500000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,2014-05-07 14:30:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,2014-05-07 14:30:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,158500000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,2014-05-07 14:30:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,2014-05-07 14:30:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,154633853.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,2014-05-07 14:30:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,2014-08-06 19:41:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,26828917.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,2014-08-06 19:41:22+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1801925.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,2014-08-06 19:41:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,28630842.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,2014-08-06 19:41:22+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1689358.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,2014-08-06 19:41:22+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1689358.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,2014-08-06 19:41:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,26941484.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,2014-08-06 19:41:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7509872.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,2014-08-06 19:41:22+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,19023444.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,2014-08-06 19:41:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12300483.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,2014-08-06 19:41:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,38833799.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,2014-08-06 19:41:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11892315.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,2014-08-06 19:41:22+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,811782.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,2014-08-06 19:41:22+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5334.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,2014-08-06 19:41:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-806448.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,2014-08-06 19:41:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12698763.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,2014-08-06 19:41:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12698763.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,2014-08-06 19:41:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12698763.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,2014-08-06 19:41:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12698763.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,2014-08-06 19:41:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,158700000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,2014-08-06 19:41:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,2014-08-06 19:41:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,158700000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,2014-08-06 19:41:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,2014-08-06 19:41:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,166016719.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,2014-08-06 19:41:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,31222302.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1482733.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,32705035.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,-829770.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,-829770.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,33534805.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11675857.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,22252908.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12285941.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,46214706.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12679901.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1436007.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5127.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,837.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1430043.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14109944.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14112944.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14112944.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14112944.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,162700000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,162700000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,161269021.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
